Stay updated on Safety of Doxorubicin & Pembrolizumab in Sarcoma Clinical Trial

Sign up to get notified when there's something new on the Safety of Doxorubicin & Pembrolizumab in Sarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of Doxorubicin & Pembrolizumab in Sarcoma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision updated from v3.5.3 to v3.5.4 on the page. This appears to be a small metadata or formatting update and does not modify study details, eligibility criteria, or results.
    Difference
    0.1%
    Check dated 2026-05-15T06:55:26.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    39 days ago
    Change Detected
    Summary
    The page’s ClinicalTrials.gov UI/version footer was updated from **v3.5.2** to **v3.5.3**, indicating a site revision rather than a change to the study record content.
    Difference
    0.1%
    Check dated 2026-04-24T06:28:01.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:41:47.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Added the related MeSH term 'Primary interstitial lung disease specific to childhood' to the page's related topics/MeSH terms.
    Difference
    0.1%
    Check dated 2026-04-02T15:35:41.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    The page revision header was updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T05:21:23.000Z thumbnail image
  9. Check
    82 days ago
    Change Detected
    Summary
    Page revision updated to v3.4.3; the previous revision v3.4.2 was superseded.
    Difference
    0.1%
    Check dated 2026-03-12T02:22:21.000Z thumbnail image

Stay in the know with updates to Safety of Doxorubicin & Pembrolizumab in Sarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of Doxorubicin & Pembrolizumab in Sarcoma Clinical Trial page.